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ABSTRACT 
Objective: To develop and validate an easy and sensitive HPLC method for quantitation of metformin in urine. 
Methods: The technique involved deproteinisation of urine sample with methanol and analysis of the supernatant the usage of Zorbax 300–SCX, 4.6 
X 150 mm ID, 5 µm particle size and UV detection at a wavelength of 233 nm. 
Results: The assay was specific for metformin and linear from 1.25 to 50.0μg/ml. The relative standard deviation of intra-and inter-day assays was 
lesser than 7%. The recovery of metformin from urine ranged from 97-103%. 
Conclusion: An easy and sensitive HPLC approach for quantitation of metformin in urine had been developed. Due to its simplicity in sample 
preparation and instrumentation, this technique can be used for pharmacokinetic studies of metformin in urine samples. 
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INTRODUCTION 
Metformin HCL (N, N-dimethyl imido dicarbonimidic diamide 
hydrochloride) (MET) is the first desire of oral hypoglycemic drug 
used within the remedy of non-insulin structured diabetes Mellitus 
(DM), through enhancing glycemic control thereby stops 
gluconeogenesis and glycogenolysis [1]. Being an uncrowned queen, 
MET serves justice for the reason that FDA approved aid of United 
States in 1995 until date, which has paved its manner to good-sized 
boom in medical use [2]. Metformin is absorbed slowly submit oral 
administration, approximately 60% is eliminated in urine as such 
within 24 h, and almost 30% of the drug dosage is non-absorbed and 
excreted in faeces [2]. Urine is a non-invasive sample series 
technique and the estimation of drug tiers in urine is simpler when 
in comparison to plasma and different organic body fluids that are 
complex [3]. 
Metformin is an extremely polar and small molecule, which has first-
rate solubility in water and relatively poor lipid solubility. 
Therefore, it can be retained in reverse phase (RP) HPLC columns. 
Numerous methods are available to quantitate MET in urine. They 
encompass capillary electrophoresis with the detector of contactless 
conductivity [4], voltammetric approach [5], and cation alternate 
HPLC [6], reverse phase HPLC [7-9] and liquid chromatography 
mass spectrometry (LCMS) [10]. These methods had complicated 
sample extraction technique and improved run time. 
In gasoline chromatography, chemical derivatization was applied [11-
13]. FT-IR (Fourier Transformation Infrared) and mass spectroscopic 
techniques [14] and electrochemiluminescence coupled with capillary 
electrophoresis [15] are other existing methodologies. However, the 
complexity is levelled up in these techniques, though they prove to be 
advantageous in terms of sensitivity.  
Hence, LC is preferred mostly in biological laboratories. Although 
LCMS methodology had been implied for MET quantification, and 
techniques are efficient for selectivity and sensitivity with brief 
retention time, these techniques are too luxurious in growing 
international locations and aid poor settings. 
We developed a simple HPLC method with simple sample extraction 
and preparation procedure using a conventional RP Zorbax SCX 
Column to estimate urine MET [16]. Similar to this method, in 
particular to the matrix difference, we have developed and validated 
a specific methodology for urine MET.  
MATERIALS AND METHODS 
Metformin 
Pure MET Hydrochloride was a kind gift from M/s Aarthi Drugs Ltd. 
Methanol (99.80% purity), Acetonitrile (99.9% purity), Potassium 
dihydrogen phosphate (99.5% purity), Dipotassium hydrogen 
orthophosphate (99% purity) were purchased from M/s Qualigens 
(India) Ltd. Deionized water was processed through a water 
purification system (Siemens, Germany). Urine sample was obtained 
from normal healthy volunteers, Chennai, India. 
Chromatographic system  
HPLC instrumentation (Shimadzu Corporation, Kyoto, Japan) 
consisted of pumps (LC-20AD), photodiode array detector 
(SPDM20A) and automatic sampler (SIL20AC-HT) with constructed 
gadget controller. Lab solutions software program was used for 
collection and acquisition of data. The analytical column used was 
Zorbax 300–SCX, 4.6 X 150 mm ID, 5 µm particle length (Agilent, 
USA) covered by way of a well-suited protect column. An isocratic 
mobile phase is a mixture of 10 mmol phosphate buffer (1.625 gm of 
KH2PO4 and 0.3 gm of K2HPO4 in 1000 ml of MQ Water, pH 4.8) and 
acetonitrile in the ratio of 55: 45 (v/v) was used to split the analyte 
from the endogenous additives. Before the preparation of the mobile 
phase, the solvents had been degassed using a Millipore vacuum 
pump. The PDA detector was tuned at the wavelength of 233 nm. 
The chromatogram was run for 8 min at 1.3 ml flow rate per min. 
The column temperature turned into at 30◦C. Unknown 
concentrations had been derived from linear regression evaluation 
vs. Concentration curve. The linearity changed into established the 
usage of estimates of correlation coefficient (r). 
Preparation of standard solution  
A stock solution (1 mg/ml) was prepared by dissolving MET HCL in 
methanol. The working standards of MET in concentrations ranging 
from 1.25µg/ml to 50µg/ml were prepared in pooled urine. 
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Sample preparation  
To 900 ul of distilled water, 100 µl of urine was added (1:10 
dilution). To 400 µl of calibration standards or test samples, 450 µl 
of methanol was added and the contents had been vortexed 
vigorously for 3 min and centrifuged at 10,000 RPM for 10 min. 75 µl 
of the supernatant was injected into the HPLC column 
Method validation parameters 
Method validation were carried out as per ICH guidelines [17] 
Accuracy and linearity  
The accuracy and linearity of MET standards were evaluated by means 
of measuring a fixed of standards starting from 50 to 1.25µg/ml. By 
processing each standard in multiples for six consecutive days, the 
intra-day and inter-day variations were decided. 
Precision 
The precision of this method was calculated by analyzing different 
concentrations of MET in pooled urine samples in replicates on 
three successive days. 
Recovery  
On three unique events, the recuperation experiments were done. 
Known concentrations of MET (2.5, 10 and 50µg/ml) had been made 
in pooled urine and were spiked with lower, median and maximum 
concentrations of standards. The percentage of drug restoration 
from urine samples was calculated by dividing the difference in MET 
concentrations with the aid of the estimated concentration. 
Specificity  
Interference from endogenous compounds was ruled out by 
investigating blank pooled urine samples. Interference from anti-TB 
drugs-rifampicin, isoniazid, ethambutol, pyrazinamide, levofloxacin, 
cycloserine, ethionamide, rifapentine, anti-retroviral tablets–
nevirapine, efavirenz, lamivudine, stavudine, zidovudine and anti-
diabetic capsules-sulphonyl ureas–glibenclamide at a concentration 
of 10.0µg/ml were evaluated. 
Limit of detection (LOD) and quantitation (LOQ)  
The lower restriction of quantification became the lower maximum 
attention of the analyte that would be determined with proper precision 
and accuracy. These values have been envisioned mathematically from 
the standard curve equations. LOD calculations were done by the usage 
of the formula 3.3 x o/S, where o is the usual deviation of Y-axis 
intercepts and S is the slope of the calibration curve. 
Clinical application 
We have applied this method for the estimation of urine MET in 
diabetes mellitus patients who were part of a pharmacokinetic 
study. These patients received MET 500 mg and the urine samples 
collected after administration (0-8 h). Informed written consent was 
obtained from them prior to sample collection.  
RESULTS 
Under the chromatographic conditions described above, MET 
became well separated and seen as a discrete peak inside the 
representative chromatograms of extracted urine standards 50, 5.0 
and 1.25 µg/ml and an extracted pattern from DM patient (fig. 1-5). 
No peak was observed at the retention time of MET (fig. 1E) in the 
blank urine sample. In the prevailing approach, urine MET 
concentrations ranging from 1.25–50 µg/ml were checked for 
linearity. These concentrations span the range of therapeutic 
interest. The suggest correlation coefficient (r), coefficient of 
determinants (R2), slope and intercept values have been 0.998, 
0.999, 0.9893,14026 and 4321.4, respectively (fig. 6). The linearity 
and reproducibility of the various standards used for building 
calibration graphs for urine MET are given (table 1). The intra-and 
inter-day relative standard deviation (RSD) for requirements 
containing 1.25–50 µg/ml ranged from 0.1% to 4.1% and 0.4% to 
0.6% respectively. The accuracy of urine MET concentrations ranged 
from 96% to 107%. 
 
 
Fig. 1: Chromatogram of extracted urine metformin standard 50.0 µg/ml 
 
Table 1: Linearity and reproducibility of urine metformin 
Standard concentration (µg/ml)   Mean peak height+SD (%RSD) 
Within day (n=6) Between day (n=6) 
50 690130.8+12575.99 (1.82) 709577.8+2575.7 (0.36) 
25 361542+377.2 (0.1) 354458.5+23489.37 (6.63) 
10 143415.3+120.01 (0.08) 146787.5+5221.56 (3.56) 
5 72206+1015.9 (1.41) 75866.3+1799.58 (2.37) 
2.5 36604.5+1512.3 (4.13) 35947.3+351.8 (0.98) 
1.25 17782.5+113.5 (0.64) 19008+1182.82 (6.22) 
SD =Standard deviation, RSD= Relative standard deviation, n=number, µg/ml =microgram per milliliter 
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Fig. 2: Chromatogram of extracted urine metformin standard 5.0 µg/ml 
 
 
Fig. 3: Chromatogram of extracted urine metformin standard 1.25 µg/ml 
 
 
Fig. 4: Chromatogram of extracted urine metformin from a DM patient 
 
The precision of the method was checked by analyzing three urine 
samples containing various concentrations of MET (table 2). The 
relative standard deviation (RSD) for those samples ranged from 
97% to 104%, respectively. The LOD and LOQ predicted 
mathematically from the standard curve equation were 50 and 
1.25µg/ml, respectively. This method reliably removed interfering 
substances from urine, yielding a recovery for MET that ranged 
from 97 % to 103% (table 3). Interference from endogenous 
compounds changed into investigated by way of measuring blank 
urine samples. 
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Fig. 5: Chromatogram of extracted blank urine 
 
 
Fig. 6: Calibration curve of urine metformin 
 
Table 2: Recovery of urine metformin 
Base Added (µg/ml) Actual (µg/ml) Obtained (µg/ml) Recovery (%) 
50 12.5 30 30.91 103 
10 5 7.5 7.28 97 
2.5 1.25 1.875 1.83 97 
µg/ml =microgram per milliliter 
 
Table 3: Precision of urine metformin 
Actual concentration (µg/ml) Found concentration (µg/ml) mean+SD % RSD 
50 49.7+0.27 99 
10 10+0.01 100 
1.25 1.3+0.01 104 
SD =Standard deviation, RSD =Relative standard deviation, n =number, µg/ml =microgram per millilitre  
 
Interference from certain anti-TB drugs such as Rifampicin, 
Rifabutin, Rifapentine, Pyrazinamide, Moxifloxacin, Lipoic acid, 
Levofloxacin, Ethionamide, Delamanid, Clofazimine, Bedaquiline, 
Cycloserine Isoniazid, anti-retroviral drugs like Efavirenz, anti-
hypertensive drugs like Nor-verapamil, Verapamil and anti-diabetic 
drugs-Sulphonylureas are Glipizide, Glibenclamide, Glimmered were 
assayed and this method was specific for urine MET and none of 
these drugs showed any interference. The urine was collected from 
two diabetic patients was analyzed. The mean percentage of urine 
MET concentration in DM patients was 54%.  
DISCUSSION 
Many of the present methods rent one-of-a-kind techniques for 
sample extraction together with the acetone precipitation approach 
[18], solid section extraction [19], ion-pair strong section extraction 
[20, 21], liquid-liquid ion-pair extraction [22-23], liquid-liquid 
extraction [24], protein precipitation and extraction into one step 
[25]. The extraction of the sample is quite complicated and time 
taking because of the polar nature of MET. The run time of the 
prevailing methods was greater than 9 min while our developed 
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method has a shorter runtime of eight minutes [26]. Even the 
injection quantity of the sample became higher in most of the 
methods. Therefore, the technique developed involved simple 
extraction, which stays smooth, less tedious and the compound of 
interest become extracted in the usage of organic solvent. 
We present a simple HPLC method for detection of urine MET using 
lesser quantity of sample. The calibration curve turned into linear in 
the span of 1.25–50µg/ml (r2 =0.998). The validation parameters 
are desirable for the estimation of the analyte in urine samples. We 
bear in mind this technique to be precise, accurate and reproducible. 
The developed technique discovered to be less complicated to carry 
out than the posted techniques for determination of MET in urine. 
CONCLUSION 
We have defined a simple, touchy, and specific HPLC approach for 
the quantitation of MET in urine. The advantageous method became 
tested as per Bioanalytical approach validation pointers. The 
technique concerned a simple pattern dilution procedure that's 
precise, reproducible and economic for the quantitation of MET in 
urine. The run time becomes 8 min and could be proved as better 
opportunity for steeply-priced liquid chromatographic-mass 
spectrometric technique. Urine MET method developed may be apt 
for pharmacokinetic and bioavailability studies. 
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